Why is Krebs Biochem falling/rising?

As of 24-Jul, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 80.00, which reflects a decrease of Rs 3.2 or 3.85%. Today's price summary indicates that the stock underperformed its sector by 4.2%, opened with a loss of 3.85%, and reached an intraday low of Rs 80. The stock has shown a negative performance over various time frames, with a 1-week return of -1.51%, a 1-month return of -9.09%, and a year-to-date decline of -13.51%. The company has declared negative results for the last two consecutive quarters, with a significant drop in profits and a high debt-to-equity ratio, contributing to its weak long-term fundamental strength.
In the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has shown a slight increase of 0.16% over the past month. The stock's recent trading activity has been erratic, with it not trading on one day out of the last 20 days, indicating potential liquidity issues. Despite a rise in investor participation, as evidenced by a 240.96% increase in delivery volume, the overall sentiment remains negative due to the company's poor financial health and declining profitability, which has led to its underperformance relative to the benchmark indices over the past year and beyond.